Eagle Pharmaceuticals
EGRX
#11130
Rank
A$4.93 M
Marketcap
A$0.37
Share price
0.00%
Change (1 day)
-80.49%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$4.93 Million

As of November 2026 Eagle Pharmaceuticals has a market cap of A$4.93 Million. This makes Eagle Pharmaceuticals the world's 11130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$4.93 M-43.36%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$984.05 B 19,957,216.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$439.40 B 8,911,384.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$1.846 T 37,443,876.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$359.91 B 7,299,288.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$182.49 B 3,701,067.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$145.96 B 2,960,242.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$73.86 B 1,497,901.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel